52.66
price up icon0.11%   0.06
after-market アフターアワーズ: 52.00 -0.66 -1.25%
loading

Merus N V (MRUS) 最新ニュース

pulisher
Jun 18, 2025

Merus gains after mid-stage trial data for lead asset in head and neck cancer - MSN

Jun 18, 2025
pulisher
Jun 15, 2025

(MRUS) Technical Data - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 13, 2025

Merus N.V.’s SWOT analysis: promising antibody platform drives stock potential By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

Merus N.V.’s SWOT analysis: promising antibody platform drives stock potential - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 11, 2025

Bicara Therapeutics Looks To Reclaim Some Of The Spotlight From Merus (NASDAQ:BCAX) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 10, 2025

The Netherlands: Merus raises US$300m from underwritten public offering - Investors in Healthcare

Jun 10, 2025
pulisher
Jun 08, 2025

Why Merus N.V. (MRUS) Crashed On Wednesday - MSN

Jun 08, 2025
pulisher
Jun 05, 2025

Merus N.V. announces proposed public offering of common shares - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Merus dips 7%, prices $300M stock at $57 per share - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Merus Announces Public Offering of Common Shares - TipRanks

Jun 05, 2025
pulisher
Jun 04, 2025

Merus Raises $300m After ASCO Success - insights.citeline.com

Jun 04, 2025
pulisher
Jun 04, 2025

Sector Update: Health Care Stocks Mixed Premarket Wednesday - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

MRUS: Joint Managers Lead Successful Offering | MRUS Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Merus Prices $300 Million Stock Offering - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Merus N.V. (MRUS) Launches $300M Public Offering - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Merus N.V. announces public offering of common shares By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

Merus Prices 5.26 Mln Shares At $57/Shr In Public Offering; To Raise Around $300 Mln - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

Merus N.V. Announces Pricing of Public Offering of Common Shares - The Manila Times

Jun 04, 2025
pulisher
Jun 03, 2025

Merus N.V. Announces Proposed Public Offering of Common Shares | - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Merus (MRUS) Initiates Public Offering to Fund Development | MRU - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Merus (MRUS) Initiates Public Offering to Fund Development | MRUS Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Merus N.V. announces public offering of common shares - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Merus Plans Public Share Offering - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Drugmaker Merus slips after share offering launch - TradingView

Jun 03, 2025
pulisher
Jun 03, 2025

Merus N.V. Announces Proposed Public Offering of Common Shares - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

How to Take Advantage of moves in (MRUS) - news.stocktradersdaily.com

Jun 03, 2025
pulisher
Jun 01, 2025

e.l.f Beauty, Box And Joby Aviation Are Among Top 11 Mid-Cap Gainers Last Week (May 26-May 30): Are Others In Your Portfolio? - Benzinga

Jun 01, 2025
pulisher
May 29, 2025

Merus, N.V. Provides Updates on Clinical Development - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Merus NV Stock Skyrockets 8%: Bull Run Intact or Peak Approaching? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 29, 2025

Merus Announces Promising Phase 2 Trial Results - TipRanks

May 29, 2025
pulisher
May 29, 2025

ASCO25: Merus wins in head-to-head with Bicara for head and neck cancer - Yahoo Finance

May 29, 2025
pulisher
May 27, 2025

Merus to Present at Upcoming Investor Conferences - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Merus Showcases Next-Gen Cancer Antibody Platform at Two Premier Healthcare Conferences - Stock Titan

May 27, 2025
pulisher
May 27, 2025

Merus stock holds $85 target, Buy rating at H.C. Wainwright - Investing.com

May 27, 2025
pulisher
May 27, 2025

Merus stock holds $85 target, Buy rating at H.C. Wainwright By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Merus (MRUS) Stock: Analysts Rally Behind Biotech After Cancer Treatment Breakthrough - CoinCentral

May 27, 2025
pulisher
May 27, 2025

Merus (NASDAQ:MRUS) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

May 27, 2025
pulisher
May 26, 2025

Merus (NASDAQ:MRUS) Given a $110.00 Price Target by BMO Capital Markets Analysts - Defense World

May 26, 2025
pulisher
May 26, 2025

Lazard Asset Management LLC Takes Position in Merus (NASDAQ:MRUS) - Defense World

May 26, 2025
pulisher
May 26, 2025

Merus (NASDAQ:MRUS) Price Target Raised to $110.00 - Defense World

May 26, 2025
pulisher
May 25, 2025

BofA Maintains Buy Rating on Merus (MRUS), Lifts PT - Yahoo Finance

May 25, 2025
pulisher
May 25, 2025

Merus N.V.’s SWOT analysis: promising cancer drug pipeline boosts stock outlook - Investing.com Australia

May 25, 2025
pulisher
May 25, 2025

Merus (MRUS) Price Target Raised at BMO After Positive Phase 2 Data - MSN

May 25, 2025
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
大文字化:     |  ボリューム (24 時間):